IBDEI17Y ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21811,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,21811,1,5,0)
 ;;=5^Family H/O Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,21811,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,21812,0)
 ;;=V17.3^^133^1320^15
 ;;^UTILITY(U,$J,358.3,21812,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21812,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,21812,1,5,0)
 ;;=5^Family H/O Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,21812,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,21813,0)
 ;;=V16.6^^133^1320^16
 ;;^UTILITY(U,$J,358.3,21813,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21813,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,21813,1,5,0)
 ;;=5^Family H/O Leukemia
 ;;^UTILITY(U,$J,358.3,21813,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,21814,0)
 ;;=V18.61^^133^1320^19
 ;;^UTILITY(U,$J,358.3,21814,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21814,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,21814,1,5,0)
 ;;=5^Family H/O Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,21814,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,21815,0)
 ;;=V17.0^^133^1320^20
 ;;^UTILITY(U,$J,358.3,21815,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21815,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,21815,1,5,0)
 ;;=5^Family H/O Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,21815,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,21816,0)
 ;;=V19.4^^133^1320^21
 ;;^UTILITY(U,$J,358.3,21816,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21816,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,21816,1,5,0)
 ;;=5^Family H/O Skin Condition
 ;;^UTILITY(U,$J,358.3,21816,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,21817,0)
 ;;=V17.1^^133^1320^22
 ;;^UTILITY(U,$J,358.3,21817,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21817,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,21817,1,5,0)
 ;;=5^Family H/O Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,21817,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,21818,0)
 ;;=V16.8^^133^1320^18
 ;;^UTILITY(U,$J,358.3,21818,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21818,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,21818,1,5,0)
 ;;=5^Family H/O Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,21818,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,21819,0)
 ;;=V11.1^^133^1320^23
 ;;^UTILITY(U,$J,358.3,21819,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21819,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,21819,1,5,0)
 ;;=5^Hx Of Affective Disorder
 ;;^UTILITY(U,$J,358.3,21819,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,21820,0)
 ;;=V15.89^^133^1320^46
 ;;^UTILITY(U,$J,358.3,21820,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21820,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,21820,1,5,0)
 ;;=5^Hx Of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,21820,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,21821,0)
 ;;=V11.3^^133^1320^24
 ;;^UTILITY(U,$J,358.3,21821,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21821,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,21821,1,5,0)
 ;;=5^Hx Of Alcoholism
 ;;^UTILITY(U,$J,358.3,21821,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,21822,0)
 ;;=V15.07^^133^1320^35
 ;;^UTILITY(U,$J,358.3,21822,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21822,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,21822,1,5,0)
 ;;=5^Hx Of Latex Allergy
 ;;^UTILITY(U,$J,358.3,21822,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,21823,0)
 ;;=V13.4^^133^1320^25
 ;;^UTILITY(U,$J,358.3,21823,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21823,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,21823,1,5,0)
 ;;=5^Hx Of Arthritis
 ;;^UTILITY(U,$J,358.3,21823,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,21824,0)
 ;;=V12.72^^133^1320^27
 ;;^UTILITY(U,$J,358.3,21824,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21824,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,21824,1,5,0)
 ;;=5^Hx Of Colon Polyps
